 Announcement
July 10, 2024
Press Release Analysis: Kaltura’s Influence on Higher Education and Corporate Client Performance Video Continues to Power Higher EducationIn a recent study conducted by Kaltura Inc., the integration of video technology in the education sector continues to grow at an impressive rate. According to the findings, 63%...
|
Announcement
July 10, 2024
In a move to bolster its emergency response capabilities, Santa Barbara County has partnered with Genasys Inc, the leading provider of Protective Communications solutions. The county has signed a new contract with Genasys to deploy their cutting-edge Genasys EVAC (EVAC) system, joining the ranks of 36 other Californ...
|
Business Update
July 10, 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, recently announced the completion of patient enrollment for the TETON 2 study. This significant milestone is part of their larger, global TETON clinical trial program aimed at evaluating...
|
|
 Clinical Study
July 10, 2024
In recent groundbreaking news, renowned biotechnology firm CARGO Therapeutics has unveiled their exceptional Firi-cel CAR T-Cell Therapy in a Phase 1 Clinical Study published in The Lancet. The study has generated significant enthusiasm within the medical community, underscoring the potential of this cutting-edge tr...
 Clinical Study
July 10, 2024
CSIMarket.com aims to provide and evidence-based information on the latest advancements in the field of pharmacology. In line with this , this article presents recent findings published in eNeuro, a peer-reviewed, open-access journal, which shed light on the potential effectiveness of OV329 in the treatment of re...
|
|
Our most Popular Articles
|
Clinical Study
March 7, 2024
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson s Disease at AD/PD 2024Parkinson s disease is a debilitating neurodegenerative disorder that affects millions of people worldwide. Characterized by the gradual loss of dopamine-producing cells in the brain, Parkinson s lead...
|
Announcement
February 27, 2025
In a recent announcement, the Rosen Law Firm, a preeminent global investor rights law firm, has encouraged investors who purchased securities of Alarum Technologies Ltd. (NASDAQ: ALAR) between March 14 and August 26, 2024, to consider securing legal counsel ahead of a crucial deadline in an ongoing securities class ...
|
Clinical Study
July 24, 2024
In a recent announcement, Sonnet BioTherapeutics Holdings, Inc. revealed encouraging data from the Phase 1b portion of its Phase 1b/2a clinical trial evaluating SON-080 for the treatment of chemotherapy-induced peripheral neuropathy (CIPN). This milestone supports the further development of SON-080 into Phase 2, hig...
|
|
|
Company News
|
Announcement
July 10, 2024
In a move to bolster its emergency response capabilities, Santa Barbara County has partnered with Genasys Inc, the leading provider of Protective Communications solutions. The county has signed a new contract with Genasys to deploy their cutting-edge Genasys EVAC (EVAC) system, joining the ranks of 36 other Californ...
|
Business Update
July 10, 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, recently announced the completion of patient enrollment for the TETON 2 study. This significant milestone is part of their larger, global TETON clinical trial program aimed at evaluating...
|
Business Update
July 10, 2024
ICON: Leading the Charge in Clinical Research and Corporate Social Responsibility DUBLIN, March 2024 In a series of significant recognitions, ICON plc (NASDAQ: ICLR) has solidified its standing as not only a leader in clinical research but also as a paragon of corporate responsibility. This dual recognition unde...
|
|
|
Company News
 Business Update
July 10, 2024
|
Company News
 Business Update
July 10, 2024
|
Company News
 Product Service News
July 10, 2024
|
More Company News
|
Clinical Study
July 10, 2024
|
Clinical Study
July 10, 2024
|
Clinical Study
July 10, 2024
|
Product Service News
July 10, 2024
|
Product Service News
July 10, 2024
|
Product Service News
July 10, 2024
|
Contract
July 10, 2024
|
Business Update
July 10, 2024
|
Partnership
July 10, 2024
|
Stocks on the Move
July 10, 2024
|
|
|
|
Related News
|
|
Stocks on the Move
|
Stocks on the Move
|
|
Stocks
|
Stocks on the Move
|
Stocks on the Move
|
Stocks on the Move
|
|
|
|
Business News
|
 Clinical Study
In recent groundbreaking news, renowned biotechnology firm CARGO Therapeutics has unveiled their exceptional Firi-cel CAR T-Cell Therapy in a Phase 1 Clinical Study published in The Lancet. The study has generated significant enthusiasm within the medical community, underscoring the potential of this cutting-edge tr...
|
|
Clinical Study
CSIMarket.com aims to provide and evidence-based information on the latest advancements in the field of pharmacology. In line with this , this article presents recent findings published in eNeuro, a peer-reviewed, open-access journal, which shed light on the potential effectiveness of OV329 in the treatment of re...
|
|
Clinical Study
Aligos Therapeutics, a renowned clinical-stage biopharmaceutical company, has recently made significant progress in developing innovative therapeutics to combat chronic hepatitis B (CHB) and metabolic dysfunction-associated steatohepatitis (MASH). This article will outline the key findings from their KOL event, the ...
|
 Announcement
Rochester, New York Syntec Optics (Nasdaq: OPTX), a leading player in the optical solutions industry, has embarked on a series of strategic initiatives aimed at bolstering its presence in the burgeoning low Earth orbit (LEO) satellite optics market and enhancing data center optical connectivity. In a move set to m...
|
 Announcement
Press Release Analysis: Kaltura’s Influence on Higher Education and Corporate Client Performance Video Continues to Power Higher EducationIn a recent study conducted by Kaltura Inc., the integration of video technology in the education sector continues to grow at an impressive rate. According to the findings, 63%...
|
Our Most Popular Articles
|
|
Clinical Study
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson s Disease at AD/PD 2024Parkinson s disease is a debilitating neurodegenerative disorder that affects millions of people worldwide. Characterized by the gradual loss of dopamine-producing cells in the brain, Parkinson s lead...
|
 Announcement
In a recent announcement, the Rosen Law Firm, a preeminent global investor rights law firm, has encouraged investors who purchased securities of Alarum Technologies Ltd. (NASDAQ: ALAR) between March 14 and August 26, 2024, to consider securing legal counsel ahead of a crucial deadline in an ongoing securities class ...
|
 Clinical Study
In a recent announcement, Sonnet BioTherapeutics Holdings, Inc. revealed encouraging data from the Phase 1b portion of its Phase 1b/2a clinical trial evaluating SON-080 for the treatment of chemotherapy-induced peripheral neuropathy (CIPN). This milestone supports the further development of SON-080 into Phase 2, hig...
|
More News
|
 Announcement
In a move to bolster its emergency response capabilities, Santa Barbara County has partnered with Genasys Inc, the leading provider of Protective Communications solutions. The county has signed a new contract with Genasys to deploy their cutting-edge Genasys EVAC (EVAC) system, joining the ranks of 36 other Californ...
|
 Business Update
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, recently announced the completion of patient enrollment for the TETON 2 study. This significant milestone is part of their larger, global TETON clinical trial program aimed at evaluating...
|
 Business Update
ICON: Leading the Charge in Clinical Research and Corporate Social Responsibility DUBLIN, March 2024 In a series of significant recognitions, ICON plc (NASDAQ: ICLR) has solidified its standing as not only a leader in clinical research but also as a paragon of corporate responsibility. This dual recognition unde...
|
 Business Update
: Exscientia plc (Nasdaq: EXAI), a leading AI-driven drug discovery company based in Oxford, England, has announced a significant expansion of its collaboration with Amazon Web Services (AWS). The partnership involves leveraging AWS s artificial intelligence (AI) and machine learning (ML) services to strengthen Exsc...
|
|
Business Update
Illuminating Innovations: Teledyne Technologies Multidimensional Impact Across Defense, Entertainment, and Clean EnergyIn a significant demonstration of its multifaceted prowess, Teledyne Technologies Incorporated (NYSE:TDY) has made substantial strides across various domains, from defense and entertainment to pio...
|
|
Product Service News
In a groundbreaking development in the field of regenerative medicine, Longeveron, a leading biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has granted its product Lomecel-B the Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of mild Alzheimer s...
|
 Clinical Study
Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage biopharmaceutical company based in Rehovot, Israel, is making significant strides in oncology, with encouraging interim results from their Phase 2 pancreatic cancer study and a key dose determination for their head and neck cancer treatment. These advancement...
|
 Clinical Study
Context Therapeutics Acquires Phase 1-ready T Cell Engager CT-95 In a move that carries promising implications for cancer therapy, Context Therapeutics has announced the acquisition of a Phase 1-ready bispecific antibody, CT-95. CT-95, a potentially first-in-class mesothelin x CD3 bispecific antibody, is designe...
|
 Clinical Study
Unicycive Therapeutics, a clinical-stage biotechnology company, has recently released positive patient satisfaction findings from a pivotal clinical trial of Oxylanthanum Carbonate (OLC). Patients participating in the trial expressed a strong preference for OLC over their prior phosphate binder therapy. Additionally...
|
 Product Service News
Dragonfly Energy Expands North American Footprint with Strategic Canadian Partnership and Innovative Solutions Reno, Nev., July 10, 2024 - Dragonfly Energy Holdings Corp (Nasdaq: DFLI), an industry leader in energy storage and the maker of Battle Born Batteries, is making significant strides in expanding its prese...
|
 Product Service News
Plug Power Continues to Lead the Way in Hydrogen Solutions and Electrification LATHAM, N.Y., June 21, 2024 - Plug Power Inc. (NASDAQ: PLUG), a global frontrunner in providing comprehensive hydrogen solutions for the green hydrogen economy, has once again showcased its unparalleled execution capabilities by successfu...
|
 Product Service News
In today s fast-paced technological landscape, companies constantly strive to provide innovative solutions and gain recognition for their industry contributions. Lantronix Inc., a leading provider of secure data access and management solutions for Internet of Things (IoT) devices, has recently been awarded the prest...
|
 Contract
In a groundbreaking move to streamline the design timelines of radar and electronic warfare (EW) capabilities, the U.S. Navy has joined forces with Mercury Systems, Inc. This collaborative effort aims to advance sensor processing technologies, which will enable the rapid development of cutting-edge systems. Mercury Systems, a leading technology company known for delivering mission-critical processing power to the edge, recently announced this groundbreaking agreement.The of this partnership is to significantly reduce the time required for the design and development processes of radar and EW capabilities. By leveraging Mercury Systems Inc. s expertise, the Navy aims to revolutionize the way these systems are created, ensuring shorter timelines and enhanced operational capabilities.
|
 Business Update
In today s rapidly evolving digital landscape, businesses worldwide are recognizing the need to transform their traditional network infrastructure to keep up with the demands of a modern, interconnected world. German companies are no exception, as they actively seek innovative solutions to boost network functionalit...
|
 Partnership
In a move to solidify its position as a leading global player in the real estate services industry, Colliers International has recently announced a groundbreaking partnership agreement with SPGI Zurich AG, a prominent Switzerland-based real estate consultancy. With its eyes firmly set on expanding its European prese...
|
 Stocks on the Move
Throughout this month, Apa Corporation shares have been struggling to keep up with the overall market performance. Year to date, the company s shares have lagged behind the market by 15.13%. Several significant events have contributed to this underperformance, including a decrease in stock value, a change in price t...
|
|
|
|
|
